晚期非小细胞肺癌表皮生长因子受体-酪酸激酶抑制剂靶向治疗进展

被引：12

作者：

洪群英

白春学

机构：

[1] 复旦大学附属中山医院呼吸科

来源：

世界临床药物 | 2012年 / 33卷 / 04期

关键词：

非小细胞肺癌; 靶向治疗; 表皮生长因子受体-酪氨酸激酶抑制剂(EGFR-TKI);

D O I：

暂无

中图分类号：

R734.2 [肺肿瘤];

学科分类号：

100117 [系统生物医学];

摘要：

随着分子生物学研究的深入,靶向治疗特别是表皮生长因子-酪氨酸激酶抑制剂(EGFR-TKI)为肺癌治疗开辟了蹊径。EGFR-TKI无论作为一线还是二、三线治疗或维持治疗对晚期非小细胞肺癌(NSCLC)均有效。本文概述EGFR-TKI在晚期NSCLC治疗中的应用进展。

引用

页码：197 / 201+210 +210

页数：6

共 5 条

[1]

Efficacy and Safety of Erlotinib in 1242 East/South-East Asian Patients with Advanced Non-small Cell Lung Cancer [J].

Mok, Tony ;

Wu, Yi-long ;

Au, Joseph Siu-kie ;

Zhou, Caicun ;

Zhang, Li ;

Perng, Reury-Perng ;

Park, Keunchil .

JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (10) :1609-1615

[2]

Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial [J].

Mitsudomi, Tetsuya ;

Morita, Satoshi ;

Yatabe, Yasushi ;

Negoro, Shunichi ;

Okamoto, Isamu ;

Tsurutani, Junji ;

Seto, Takashi ;

Satouchi, Miyako ;

Tada, Hirohito ;

Hirashima, Tomonori ;

Asami, Kazuhiro ;

Katakami, Nobuyuki ;

Takada, Minoru ;

Yoshioka, Hiroshige ;

Shibata, Kazuhiko ;

Kudoh, Shinzoh ;

Shimizu, Eiji ;

Saito, Hiroshi ;

Toyooka, Shinichi ;

Nakagawa, Kazuhiko ;

Fukuoka, Masahiro .

LANCET ONCOLOGY, 2010, 11 (02) :121-128

[3]

Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial [J].

Kim, Edward S. ;

Hirsh, Vera ;

Mok, Tony ;

Socinski, Mark A. ;

Gervais, Radj ;

Wu, Yi-Long ;

Li, Long-Yun ;

Watkins, Claire L. ;

Sellers, Mark V. ;

Lowe, Elizabeth S. ;

Sun, Yan ;

Liao, Mei-Lin ;

Osterlind, Kell ;

Reck, Martin ;

Armour, Alison A. ;

Shepherd, Frances A. ;

Lippman, Scott M. ;

Douillard, Jean-Yves .

LANCET, 2008, 372 (9652) :1809-1818

[4]

Gefitinib (IRESSA) in patients of Asian origin with refractory advanced non-small cell lung cancer: Subset analysis from the ISEL study [J].

Chang, Alex ;

Parikh, Purvish ;

Thongprasert, Sumitra ;

Tan, Eng Huat ;

Perng, Reury- Perng ;

Ganzon, Domingo ;

Yang, Chih-Hsin ;

Tsao, Chao-Jung ;

Watkins, Claire ;

Botwood, Nick ;

Thatcher, Nick .

JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (08) :847-855

[5]

Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer) [J].

Thatcher, N ;

Chang, A ;

Parikh, P ;

Pereira, JR ;

Ciuleanu, T ;

von Pawel, J ;

Thongprasert, S ;

Tan, EH ;

Pemberton, K ;

Archer, V ;

Carroll, K .

LANCET, 2005, 366 (9496) :1527-1537

← 1 →